Forest Acquisition Of Cerexa Could Set The Stage For Ceftaroline Launch In 2010
This article was originally published in The Pink Sheet Daily
Executive Summary
The acquisition of the late-stage injectable antibiotic could launch ahead of Orapem.
You may also be interested in...
Actavis Counting On Strong Product Line Depth For Avycaz Launch
The specialty pharma will take advantage of its presence in antibiotics to launch its third FDA-approved antibiotic for hard-to-treat infections before the end of the second quarter.
Optimer Looks To Partner C. Diff Candidate After Trial Success
OPT-80’s success in the clinic dramatically improves Optimer’s ability to partner the product for a healthy sum.
Optimer Looks To Partner C. Diff Candidate After Trial Success
OPT-80’s success in the clinic dramatically improves Optimer’s ability to partner the product for a healthy sum.